Cargando…
Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value
Focal dystonia is a common, invalidating neurologic condition characterized by involuntary, sustained muscle contractions causing twisting movements and abnormal postures in one body part. Currently, botulinum toxin is the treatment of first choice. We performed a systematic review towards the pharm...
Autores principales: | Zoons, E., Dijkgraaf, M. G. W., Dijk, J. M., van Schaik, I. N., Tijssen, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506193/ https://www.ncbi.nlm.nih.gov/pubmed/22552527 http://dx.doi.org/10.1007/s00415-012-6510-x |
Ejemplares similares
-
PHARMACO – THERAPEUTICS OF DASEMANI DRUGS
por: Sircar, N. N.
Publicado: (1984) -
CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021) -
Pharmaco-prosthodontics revisited
por: Jagadeeshwaran, A. R., et al.
Publicado: (2012) -
ArrhythmoGenoPharmacoTherapy
por: Tosaki, Arpad
Publicado: (2020) -
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
por: Bajcar, Jana M, et al.
Publicado: (2010)